Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01388907	Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery	completed	Phase 4	61	Medtronic - MITGINDUSTRY	1	Nov 17, 2016	clinicaltrials
NCT01555073	Preemptive Analgesia Following Uterine Artery Embolization	terminated	Phase 4	23	Northwestern UniversityOTHER	1	Jul 28, 2016	clinicaltrials
NCT00613275